
Pharmaceutical companies are racing to develop new weight loss drugs following the success of Ozempic and Wegovy — and this latest round of medications could come with more health benefits and fewer side effects.
The development of new GLP-1 drugs has accelerated, NBC News reported, with experts suggesting that they could go beyond diabetes and weight loss management, improving liver and heart function while reducing side effects such as muscle loss that are common to the existing medications.